Most local anesthetics used in medicine wear off within eight to 12 hours, or at most a day. That window is often enough for a routine procedure, but it falls far short for patients who need sustained relief from surgery, trauma, or persistent pain. A research team at Boston Children's Hospital has now reported an injectable drug delivery system that kept nerves numb for two to three weeks in rats, compared with roughly four to eight hours for a widely used commercial formulation tested alongside it.
The findings, published in Nature Biomedical Engineering, point to a way of stretching the effective duration of anesthetics that are already in clinical use. Because nerve blocks tend to last longer in humans than in rats, the researchers suggest the approach could translate into meaningfully longer pain control in people, and it may have implications for other kinds of pain as well.
How liposomes control drug release
For decades, physicians have relied on liposomes — tiny spheres of fatty molecules known as lipids — as gradual drug delivery vehicles that carry medicine through the body and let it escape slowly rather than all at once.
The composition of those liposomes governs how quickly the drug leaks out, and that rate matters in two directions at the same time:
- Faster leakage produces a stronger drug effect over a shorter period.
- Faster leakage also raises the risk of greater toxicity.
A formulation that releases its payload slowly, then, is not simply more convenient. It can widen the gap between a therapeutic dose and a harmful one, holding drug concentrations in a useful range for longer instead of spiking and then fading.
An assumption about fluid lipids falls apart
Until now, researchers generally believed that drug molecules escaped fastest from liposomes built from more "fluid" lipids, and slowest from stiffer, more tightly packed ones. Yuan Wang, Ph.D., a research engineer in the laboratory of Daniel Kohane, M.D., Ph.D., upended that expectation.
Wang showed that liposomes made from more fluid lipids actually release hydrophilic drugs — molecules that mix well with water or dissolve in it — extremely slowly. In other words, the relationship between membrane fluidity and release speed depends on the type of drug being carried, and for water-loving drugs the conventional rule appears to run in reverse.
One way to make a lipid more fluid is to add many double chemical bonds to its tails. Those double bonds keep the lipids from packing together as tightly, which is precisely what loosens the membrane. The team used that property as a design lever rather than a liability.
Onion-like spheres and a longer path out
Through a series of intricate experiments, the researchers found a structural explanation for the surprise. Liposomes built with many double bonds adopted a multi-compartment architecture, while liposomes without those bonds formed a simple spherical shape.
That difference in geometry changes how far a drug molecule has to travel. In the high-double-bond liposomes, a hydrophilic drug encounters many more lipid barriers on its way out, and each additional barrier slows the release further.
"The more fluid membranes in liposomes with many double bonds may be easier to cross, but the greater number of barriers slows the drug's release," Wang said. The more fluid liposomes with abundant double bonds may arrange themselves into concentric spheres — layers much like an onion — or possibly spheres nested within spheres.
Two to three weeks of numbness in rats
The practical result of that architecture was a nerve block that outlasted the comparison formulation by a wide margin. In rats, the new slow-release injectable produced anesthetic effects lasting two to three weeks, while the commercial formulation numbed nerves for only about four to eight hours.
That gap is especially notable because laboratory animals are not the most forgiving test case. According to the researchers, nerve blocks in humans tend to work longer than they do in rats, which raises the possibility that a human version of the formulation could extend relief even further beyond the current standard.
What longer-lasting nerve blocks could change
If the effect holds up in further testing, the implications reach well beyond the operating room:
- Patients recovering from surgery could receive days or weeks of localized numbness from a single injection, rather than a regimen of repeat doses.
- Trauma and certain chronic pain conditions might be managed with fewer repeat procedures and less disruption for patients.
- Existing anesthetics, rather than entirely new drugs, could gain substantially longer action through reformulation.
The researchers note that the advancement could substantially extend the effective duration of anesthetics already in use, and that it may have implications for other types of pain. That breadth comes from the nature of the mechanism: the innovation lies in how a drug is packaged and released, not in the drug molecule itself.
Questions that remain
The results come from animal experiments, and translating them into clinical practice would require human trials along with careful attention to safety. Long-acting nerve blocks raise considerations of their own — prolonged numbness, the need to confirm that extended drug exposure does not harm nerve tissue, and the practical question of whether a weeks-long block suits every patient and every procedure.
Even so, the study challenges a long-standing assumption about how liposomes behave and turns the discovery into a design principle. By working out why fluid membranes with many double bonds hold onto water-soluble drugs so effectively, the Boston Children's Hospital team has sketched a route to pain relief measured in weeks instead of hours — a timetable that current local anesthetics simply cannot reach.
This article is based on reporting by Medical Xpress. Read the original article.
Originally published on medicalxpress.com
